CVC

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC

Retrieved on: 
Monday, April 8, 2024
Dialysis, Antibiotic, CVC, Infection, Patient, NDA, Taurolidine, Heparin, ARC, FDA, Health, Medical device

CorMedix received NDA approval of DefenCath® under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD) on November 15, 2023, and expects to begin commercialization of the product in the inpatient setting on April 15th.

Key Points: 
  • CorMedix received NDA approval of DefenCath® under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD) on November 15, 2023, and expects to begin commercialization of the product in the inpatient setting on April 15th.
  • CorMedix is committed to building meaningful long-term relationships with dialysis providers that are dedicated to innovation and infection reduction.
  • ARC Dialysis, a Miami-based medium-sized dialysis organization, provides inpatient dialysis services to approximately 100 inpatient facilities, and is the operator of 18 outpatient dialysis units throughout Florida.
  • “This agreement with CorMedix for the adoption of DefenCath reinforces our commitment to innovation and patient care, and we are proud of the reputation we’ve established for ourselves as a leading dialysis provider in the southeast United States,” says Fred Dumenigo, CEO of ARC Dialysis.

Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration

Retrieved on: 
Tuesday, March 26, 2024
Research, Legal, Medical Devices, Patent Law, Genetics, Professional Services, Biotechnology, Pharmaceutical, Health, Science, Trade, CVC, Patent, RNA, CNIPA, Emmanuelle, University, Genomics, CRISPR, Eukaryote, Intellectual property, Cas9

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the China National Intellectual Property Administration (CNIPA) in response to an invalidation challenge.

Key Points: 
  • ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the China National Intellectual Property Administration (CNIPA) in response to an invalidation challenge.
  • The decision to uphold the patent right in China follows a recent decision by the Japanese Patent Office earlier this year to uphold JP6692856, also part of the CVC portfolio1.
  • The decision by the CNIPA, fully upholding the patent, further demonstrates its validity and value as part of the patent collection for use of the CRISPR/Cas9 technology.
  • Michael Arciero, Vice-President of Intellectual Property and Commercial Development, ERS Genomics, said: “The decision by the CNIPA is testament to the strength of the foundational CVC CRISPR/Cas9 patent portfolio.

Terra Drone Invests in Aloft Technologies to Enter U.S. Market, Boost Global UTM Development

Retrieved on: 
Wednesday, March 20, 2024
Automation, Aircraft, Certification, CVC, Terra, Partnership, Insurance, Boeing, UAS, UTM, The Travelers Companies, Investment, Altitude, Corporate venture capital, Ecosystem, Advanced Air Mobility, Federal Aviation Administration, AAM, Airline

TOKYO, March 20, 2024 /PRNewswire/ -- Terra Drone Corporation (Terra Drone), a leading drone and Advanced Air Mobility (AAM) technology provider headquartered in Japan, has announced an investment in Aloft Technologies (Aloft), a company focusing on developing UTM, and a market leader in drone fleet and airspace management in the United States.

Key Points: 
  • TOKYO, March 20, 2024 /PRNewswire/ -- Terra Drone Corporation (Terra Drone), a leading drone and Advanced Air Mobility (AAM) technology provider headquartered in Japan, has announced an investment in Aloft Technologies (Aloft), a company focusing on developing UTM, and a market leader in drone fleet and airspace management in the United States.
  • This investment makes Terra Drone the largest shareholder in Aloft, with Aloft becoming an affiliate company of Terra Drone.
  • Additionally, Yuki Ueno, Terra Drone's executive officer, has been appointed to the Aloft board.
  • Together with Aloft and Unifly, a Belgium-based UTM provider being a Terra Drone subsidiary, Terra Drone is positioned to contribute to the global development of the UTM ecosystem.

Net Zero by 2050: Industrial Decarbonization Gains Momentum, 2024 Report - The Road Ahead, Technology Decoding, Investment Radar, Innovation Explorer

Retrieved on: 
Tuesday, March 19, 2024
Momentum, Climate change, Noise, CVC, Social media, Metal, Policy, News, Gitana 13, Transport, Carbon, Volume Two, The Road Ahead, Radar, CO2, Hydrogen, Traction, Weather, CCUS, Map, Foresight

DUBLIN, March 19, 2024 /PRNewswire/ -- The "Net Zero by 2050: Industrial Decarbonization Gains Momentum (Vol.2)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 19, 2024 /PRNewswire/ -- The "Net Zero by 2050: Industrial Decarbonization Gains Momentum (Vol.2)" report has been added to ResearchAndMarkets.com's offering.
  • Climate change, propelled by industrial emissions, poses severe threats to humanity through extreme weather and biodiversity loss.
  • Technology Foresights provides the Innovation Radar map and highlights the top players' innovation trends related to decarbonization.
  • Investment Radar: deals value and volume trends, VC investment activity and geographic trends, leading investors, environmental accelerators, and CVC investors and investees

JAGEX APPOINTS MARC ALLERA AS CHAIRMAN

Retrieved on: 
Wednesday, March 13, 2024
Consumer, RuneScape, Growth, CVC, Old school, BT Sport, IP, Video, Video game

CAMBRIDGE, England, March 13, 2024 /PRNewswire/ -- Jagex, a leading UK video game company and developer of the RuneScape franchise of games, is pleased to announce the appointment of Marc Allera as Chairman of the Board.

Key Points: 
  • CAMBRIDGE, England, March 13, 2024 /PRNewswire/ -- Jagex, a leading UK video game company and developer of the RuneScape franchise of games, is pleased to announce the appointment of Marc Allera as Chairman of the Board.
  • As part of the Company's new direction under CVC & Haveli ownership, the appointment of Marc is a significant addition to the leadership team, as Marc brings a depth of experience leading consumer-centric businesses across technology, telecoms and media sectors.
  • Jagex's CEO, Phil Mansell, said: "We are thrilled to welcome Marc Allera to our team as Chairman.
  • Marc Allera commented, "I'm delighted to be joining the board of Jagex at this significant stage in its development, and being able to return to the video games industry with such a great role.

EQS-News: DOUGLAS Group sets price range for its IPO

Retrieved on: 
Wednesday, March 13, 2024
CFO, Jefferies, Supervisory board, Deutsche Bank, Competition Commission, FMCG, GfK, Investment, Research, Management, Growth, Johnson & Johnson, Primary shares, UBS, Sale, Calendar, Beauty, Frankfurt Stock Exchange, IPO, CVC Capital Partners, Federal Financial Supervisory Authority, LBBW, Organization, Economics, Goldman Sachs, RBI, Citigroup, CVC, BNP Paribas, UniCredit, Intesa Sanpaolo, Security (finance)

The price range implies a total market capitalization of between 2.8 billion euro and 3.1 billion euro.

Key Points: 
  • The price range implies a total market capitalization of between 2.8 billion euro and 3.1 billion euro.
  • The German Federal Financial Supervisory Authority (BaFin) approved the securities prospectus for the public offer in Germany and listing of DOUGLAS today.
  • With our strong business model and successful growth strategy, the DOUGLAS Group is optimally positioned in a very attractive market.
  • Through Management Equity Programs, the members of the Executive Board as well as current and former managers of the DOUGLAS Group have indirectly invested in the company.

Fluidra Launches its €20 Million Venture Capital Fund, the First to Specialize in Pool and Wellness Startups

Retrieved on: 
Monday, March 4, 2024
IOT (Internet of Things), Security, Data Management, Consumer Electronics, Technology, Carriers and Services, Apps, Applications, Professional Services, Online Privacy, Fitness & Nutrition, Wearables, Mobile Technology, Software, Networks, Data Analytics, Health, Robotics, Engineering, Investment, Internet of things, Commercial, Safety, Swimming, Wellness, Science, CVC, Artificial intelligence, Renewable energy

Fluidra, a global leader in connected equipment and solutions for the pool and wellness sector, is launching Fluidra Ventures, a €20 million corporate venture capital fund (CVC) investment to lead innovation in the sector.

Key Points: 
  • Fluidra, a global leader in connected equipment and solutions for the pool and wellness sector, is launching Fluidra Ventures, a €20 million corporate venture capital fund (CVC) investment to lead innovation in the sector.
  • The goal of this first three-year phase is to build a solid portfolio of startups through investing in innovative companies.
  • The CVC will target startup initiatives that enhance efficiency, connectivity, sustainability and safety in the swimming pool and wellness business, leveraging IoT, computer vision and robotic solutions.
  • It is looking for startups that add value to the pool and wellness sector with innovative business models, fostering direct customer interaction through sales, subscriptions and other channels.

Global IV Catheters Market Insights Report 2023-2029: Peripheral Inserted Central Catheters (PICCs) Leading the Charge - ResearchAndMarkets.com

Retrieved on: 
Friday, February 23, 2024
Medical Devices, Health, Diabetes, Incidence, Alzheimer's disease, Infection, ICU, USD, European, Ageing, Growth, Cancer, Conditional sentence, Stroke, Hospital, Government, Short, ICU Medical, Prevalence, Safety, Malaria, Nutrient, PICC, Life expectancy, Injury, Patient, Dementia, Tuberculosis, CVC, Developed country, COPD, Medical device

The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%

Key Points: 
  • The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%
    The global IV catheters market report contains exclusive data on 33 vendors.
  • BD, B Braun, Terumo, Teleflex, ICU Medical, and Nipro Medical are some leading players currently dominating the global IV catheters market.
  • The continuous growth in individuals with chronic conditions and the rapidly expanding elderly population are the primary factors fueling the global demand for peripheral IV catheters.
  • The peripheral inserted central catheters (PICCs) product segment accounted for the highest market share of over 45% of the global CIVCs market.

Education Couture Unveils Three New Scholastic-Themed Hip-Hop Tracks to Celebrate National Reading Month

Retrieved on: 
Friday, March 1, 2024
Stellar, Polish notation, Education, Grammy Awards, Long Story Short, Parent, Catalog, Learning, Literacy, Stellar Awards, Music, CVC, Partnership, Entertainment

CHICAGO, March 1, 2024 /PRNewswire/ -- Education Couture , a Chicago-based organization, is thrilled to announce three new additions to their "Reading Music" catalog, set to release in March, National Reading Month in the U.S.

Key Points: 
  • CHICAGO, March 1, 2024 /PRNewswire/ -- Education Couture , a Chicago-based organization, is thrilled to announce three new additions to their "Reading Music" catalog, set to release in March, National Reading Month in the U.S.
  • These new hip-hop-influenced tracks aim to make learning fun by combining radio-ready melodies with foundational reading instructions to engage new readers.
  • Through ' Reading Music, ' we aim to make literacy engaging and accessible for communities in Chicago and beyond," said a spokesperson for Education Couture.
  • This initiative is part of a broader effort to innovate education and instill a love for reading through modern, relatable tools .

CVC Credit prices Apidos XLVII

Retrieved on: 
Wednesday, February 14, 2024
Banking, Other Professional Services, Professional Services, Finance, CLO, Credit, CVC, BNP Paribas, Lisp (programming language), Security (finance)

CVC Credit, the $43 billion dedicated credit strategy of CVC, is pleased to announce that it has successfully priced Apidos XLVII (47), a $507 million (c.€471 million) Collateralized Loan Obligation ("CLO").

Key Points: 
  • CVC Credit, the $43 billion dedicated credit strategy of CVC, is pleased to announce that it has successfully priced Apidos XLVII (47), a $507 million (c.€471 million) Collateralized Loan Obligation ("CLO").
  • Apidos XLVII is the second new CLO priced by CVC Credit’s transatlantic performing credit platform this year, following the pricing of Cordatus Opportunities Loan Fund Re-issue last week.
  • Performing Credit at CVC Credit, said: “We are pleased to have priced our first new U.S. CLO of 2024 so early in the year.
  • We are fortunate at CVC Credit to have an established track record and deep investor relationships to help us continue to grow our CLO business through market cycles.”
    Gretchen Bergstresser, Managing Partner and Global Head of Performing Credit at CVC Credit, commented: “The successful pricing of Apidos XLVII is testament to the unparalleled demand our global investors have shown for the attractive, consistent and market-leading performance our CLOs continue to generate.